Thursday, 4 July 2013

ATP Iuminescence assay for rapid tuberculosis vaccine

The FDA have an interesting poster, as part of their advancing regulatory science series, titled ‘Characterization of intracellular ATP Iuminescence assay for rapid evaluation of tuberculosis vaccine (Mycobacterium bovis BCG)’.

The FDA explains that “The current assay used to evaluate the potency of Mycobacterium bovis BCG vaccine is time-consuming, labor-intensive, and often yields irreproducible results. An assay that measures ATP levels in M. bovis through bioluminescence might solve those problems.”

The poster can be accessed at: FDA

Posted by Tim Sandle